News
U.S. Advises Older Travelers to Avoid Chikungunya Vaccine
TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible side effects. The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) issued the warning late last week.
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...
The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths. About 80,000 Ixchiq doses have ...
The US Centers for Disease Control and Prevention (CDC) is warning people planning to travel to the Region of the Indian ...
FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...
A total of 19,901 dengue cases have been reported in the country so far this year, according to the National Dengue Control ...
1don MSN
Most stories of chikungunya begin with something oddly harmless — a slight twitch in the toes or fingers. That’s when the ...
Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback